Hennion & Walsh Asset Management, Inc.
Position in BMY — Bristol Myers Squibb Co
CIK 1861642
Parsippany, NJ
Position in BMY
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$1,039,752
-$81,969 QoQ
Shares Held
18,045
-2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#47
of 152 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $55,949,166 across 10 Drug Manufacturers - General names. BMY ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,360 | $17,223,816 | |
| 2 | JNJ |
Johnson & Johnson
|
43,755 | $11,112,457 | |
| 3 | MRK |
Merck & Co., Inc.
|
72,515 | $9,318,177 | |
| 4 | ABBV |
AbbVie Inc.
|
23,832 | $5,997,084 | |
| 5 | GRFS |
Grifols SA
|
592,173 | $4,192,584 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
28,507 | $3,601,574 | |
| 7 | AMGN |
Amgen Inc
|
7,665 | $2,775,649 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
18,045 | $1,039,752 |
All Filings in BMY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,039,752 | 18,045 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,121,721 | 18,495 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $690,809 | 12,807 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $582,511 | 12,916 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $845,162 | 18,258 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,059,396 | 17,370 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $1,340,358 | 23,698 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,852,912 | 35,812 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,257,736 | 54,364 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $3,278,311 | 60,452 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $3,260,904 | 63,553 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $3,704,635 | 63,829 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $4,386,074 | 68,586 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,569,331 | 65,926 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $5,143,417 | 71,486 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $4,528,788 | 63,705 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,415,256 | 70,328 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $4,738,040 | 64,878 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $3,881,412 | 62,252 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,488,426 | 58,956 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,143,575 | 62,011 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,424,928 | 54,252 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||